Why Your Sugar Cravings Disappear on GLP-1 Therapy Semaglutide reduces appetite by activating GLP-1 receptors in the hypothalamus and amygdalabrain regions that control hunger, food reward, and emotional eating
The Wegovy pill is semaglutide, and semaglutide has years of evidence behind it
When it comes to Ozempic (semaglutide) , a medication originally approved for type 2 diabetes and now widely discussed for its weight management effects , real-world reviews have become an important part of the conversation
Healio Gastroenterology thanks Rita Basu, MD, Scott Isaacs, MD, FACP, FACE, Rohit Loomba, MD, MHSc, and Arul Sanyal, MD, for their views into how the fields of hepatology and endocrinology are tackling the use of GLP-1s for the treatment of patients with MASH and/or obesity and type 2 diabetes